Studies in humans revealed that topical administration of NGF was a promising approach for the treatment of cutaneous pressure ulcers [27], and the topical application of NGF may also represent a new useful tool for the management of difficult diabetic ulcers or severe pressure ulcers [28,29]. The gene discussed is NGF; the disease is decubitus ulcer.